PRJNA874676
Solid tumor all-target genetic testing
It covers 654 genes related to tumor development, detects multiple gene variants, identifies tumor-related somatic variants and germline variants, and provides a reference for tumor targeting therapy, tumor genetic assessment, and chemotherapy drug selection.It can provide a reference for tumor targeting therapy, tumor genetic evaluation, and chemotherapy drug selection. It also detects immunotherapy-related indicators such as PD-L1 expression level, tumor mutational burden (TMB), microsatellite (MSI) status, HLA typing, tumor neoantigen load (TNB), and so on, to provide more information for tumor immunotherapy. etc., to provide more comprehensive reference information for tumor immunotherapy.